23ANDME, INC. | MedPath

Three Major Trends Reshaping Precision Medicine: AI, CRISPR, and mRNA Technologies Lead Innovation

8 months ago

• Precision medicine deals reached $97.39 million in 2023, with cell therapies projected to generate over $52 billion by 2029, marking significant growth in personalized treatment approaches. • AI is revolutionizing precision medicine by accelerating genomic data analysis, drug discovery, and enabling personalized treatment predictions through platforms like Tempus and Foundation Medicine. • CRISPR gene editing achieved a milestone with FDA approval of Casgevy for sickle cell disease, while mRNA technology expands beyond COVID-19 with Moderna's mRESVIA approval for RSV.